Tandem Health is a technology company.
Tandem Health has raised $60.0M across 2 funding rounds.
Tandem Health has raised $60.0M in total across 2 funding rounds.
Tandem Health has raised $60.0M in total across 2 funding rounds.
Tandem Health's investors include Kinnevik, Northzone.
Tandem Health is a Swedish healthtech company founded in 2023 that builds an AI-powered medical scribe and clinician co-pilot to automate clinical documentation and reduce administrative burdens for healthcare providers.[1][2][3][4] Its core product listens to patient consultations, transcribes them using speech recognition and fine-tuned LLMs, generates draft notes with clinical coding, and integrates seamlessly into over 50 electronic health record (EHR) systems across Europe, supporting 50+ languages and specialties like primary care, mental health, dentistry, and physiotherapy.[1][3][4] Serving over 1,000 healthcare organizations and tens of thousands of clinicians in 11 countries—including a partnership with Accurx reaching 200,000 NHS professionals in the UK—the platform has generated 2.2 million notes, capturing 0.2% of European patient encounters while ensuring CE-marked, GDPR-compliant, and MHRA-registered operations.[1][2][3][4][5] In late 2025, it raised $50M (€40M) in Series A funding led by Kinnevik, with Northzone and others, to expand into a full AI-native operating system for workflows like care coordination and decision support.[2][3]
The company addresses clinicians spending ~40% of time on admin amid clinician shortages and aging populations, enabling more patient-focused care with faster, accurate notes and one-click EHR transfers.[3][4] Growth is rapid: from startup two years prior to widespread adoption, high clinician satisfaction (e.g., 100% at some UK surgeries), and plans to double UK staff for 98% GP penetration.[1][5]
Tandem Health was founded in 2023 in Sweden by CEO and co-founder Lukas Saari, alongside a team where over 80% are clinicians (excluding tech staff), blending AI expertise with deep medical knowledge.[1][3][7] Key advisors include Björn Zoega, former CEO of Karolinska University Hospital, and medical operations leads like Dr. Daniele Rodolico (Italy) and Dr. Oliver Sjögren (Norway).[7] The idea emerged to tackle excessive admin time in healthcare—evident from global strains like rising costs and shortages—by creating a trusted AI scribe that starts with recording consultations, transcribes via speech-to-text and LLMs, and auto-generates compliant notes.[1][3]
Early traction built quickly: within two years, it produced 2.2 million notes, integrated with 50+ EHRs (out of ~500 in Europe), and expanded to 11 countries with local operations in Nordics, UK, France, Spain, Germany, Italy, Estonia, and Netherlands.[1][7] Pivotal moments include the Accurx partnership for NHS scale and the 2025 Series A, fueling European dominance as Europe's leading medical AI co-pilot.[2][3][5]
(Note: A separate U.S.-focused "Tandem" at withtandem.com automates prior authorizations/pharmacy routing, but lacks overlap with this Europe's Tandem Health.[8])
Tandem rides the AI-in-healthcare wave, specifically ambient clinical documentation and LLM-driven workflow automation, amid global pressures like clinician burnout (40% admin time), shortages, and aging demographics straining systems.[2][3] Timing is ideal in the "LLM era," where AI scribes are becoming standard—clinicians won't revert—and Europe's fragmented markets (500+ EHRs, multilingual) demand localized, compliant tools Tandem excels at via 11-country ops.[1][2][3] Market forces favor it: regulatory approvals (CE/MHRA), NHS partnerships, and €40M funding accelerate amid €50B+ European healthtech investment trends.
It influences the ecosystem by normalizing AI copilots, enabling "AI-native" care (e.g., point-of-care decisions), and setting trust benchmarks—pioneering large-scale deployments like UK's NHS rollout, inspiring U.S./global adoption while prioritizing safety over hype.[2][5][6]
Tandem is primed to dominate Europe's AI healthtech as the go-to co-pilot, expanding from scribe to comprehensive OS with coding, coordination, and decision tools—targeting full workflow transformation.[2][3] Key trends like AI regulation maturation, LLM advances, and telehealth growth will propel it, especially in NHS secondary/private care and beyond Europe.[5] Influence may evolve to global leader, potentially via U.S. entry, as it scales to 98% UK GPs and leverages clinician-led trust for sticky adoption.[5] Returning to its core: by reclaiming patient time, Tandem exemplifies AI's potential to humanize overburdened healthcare.[1][3]
Tandem Health has raised $60.0M across 2 funding rounds. Most recently, it raised $50.0M Series A in June 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2025 | $50.0M Series A | Kinnevik, Northzone | |
| Jun 1, 2024 | $10.0M Seed | Kinnevik, Northzone |